posted on 2022-01-20, 06:33authored byJackie M. Poos, Katrina M. Moore, Jennifer Nicholas, Lucy L. Russell, Georgia Peakman, Rhian S. Convery, Lize C. Jiskoot, Emma van der Ende, Esther van den Berg, Janne M. Papma, Harro Seelaar, Yolande A. L. Pijnenburg, Fermin Moreno, Raquel Sanchez-Valle, Barbara Borroni, Robert Laforce, Mario Masellis, Carmela Tartaglia, Caroline Graff, Daniela Galimberti, James B. Rowe, Elizabeth Finger, Matthis Synofzik, Rik Vandenberghe, Alexandre de Mendonça, Pietro Tiraboschi, Isabel Santana, Simon Ducharme, Chris Butler, Alexander Gerhard, Johannes Levin, Adrian Danek, Markus Otto, Isabel Le Ber, Florence Pasquier, John C. van Swieten, Jonathan D. Rohrer
Additional file 1: Table S1. Number of control data available in each language per cognitive test. Table S2. Parameters included in the sample size calculations. Table S3. Participants characteristics and neuropsychological test results per CDR® plus NACC FTLD global score. Table S4. Number of mutation carriers that progressed on the CDR® plus NACC FTLD. Figure S1. STROBE flowchart.
Funding
Alzheimer's Research UK Alzheimer's Society Brain Research UK the Wolfson Foundation NIHR UCL/H Biomedical Research Centre Leonard Wolfson Experimental Neurology Centre Clinical Research Facility UK Dementia Research Institute UK Medical Research Council Medical Research Council NIHR Rare Disease Translational Research Collaboration MRC UK GENFI grant Bluefield project JPND GENFI-PROX grant Stichting Dioraphte the Association for Frontotemporal Dementias Research Grant 2009 Nederlandse Organisatie voor Wetenschappelijk Onderzoek ZonMw Memorabel JPND PreFrontAls consortium Alzheimer Nederland MRC Dementias Platform UK